Now showing items 1-6 of 6

    • Ficht, Allison; Good, Theresa; Carson, Ken; Lee, Sundmun (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2014-04-29)
      The present invention compositions and methods of using at least a portions of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
    • Patti, Joseph M.; Foster, Timothy J.; Hook, Magnus (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-02-23)
      Multicomponent vaccines are provided which aid in the prevention and treatment of staphylococcal infections and which include certain selected combinations of bacterial binding proteins or fragments thereof, or antibodies ...
    • Patti, Joseph M.; Foster, Timothy J.; Hook, Magnus (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2011-09-13)
      Multicomponent vaccines are provided which aid in the prevention and treatment of staphylococcal infections and which include certain selected combinations of bacterial binding proteins or fragments thereof, or antibodies ...
    • Arntzen, Charles J.; Mason, Hugh S.; Haq, Tariq A. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2001-02-27)
      The oral vaccines and oral vaccine adjuvants of the present invention are produced in transgenic plants and then administered through the consumption of the transgenic plant. DNA sequences both natural and synthetic encoding ...
    • Xu, Yi; Hook, Magnus A. O. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-09-14)
      Isolated peptide sequences and proteins containing these sequences are provided which are useful in the prevention and treatment of infection caused by Gram-positive bacteria. The peptide sequences have been shown to be ...
    • Berghman, Luc; Bottje, Walter; Hargis, Billy; Layton, Sherryll (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-02-17)
      Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a ...